Cardio-selective beta-adrenoceptor blockade and the coronary circulation

Area of Science:

• Cardiovascular Pharmacology
• Adrenoceptor Physiology

Background:

• Beta-adrenoceptors are crucial for cardiac function and vascular tone.
• Practolol is a selective beta-adrenoceptor antagonist.

Purpose of the Study:

• To investigate the role of myocardial and coronary vascular beta-adrenoceptors in regulating coronary blood flow.
• To determine the adrenoceptor subtype responsible for coronary vasoconstriction following beta-adrenoceptor blockade.

Main Methods:

• Administration of practolol to block beta-adrenoceptors.
• Stimulation of cardiac sympathetic nerves.
• Infusion of exogenous noradrenaline.
• Measurement of coronary vascular responses.

Main Results:

• Practolol blocked myocardial beta-adrenoceptors but not coronary vascular beta-adrenoceptors.
• Cardiac sympathetic stimulation and noradrenaline induced coronary vasoconstriction after practolol.
• This vasoconstriction suggests the involvement of alpha-adrenoceptors.

Conclusions:

• Myocardial beta-adrenoceptor blockade does not prevent sympathetic-mediated coronary vasoconstriction.
• Coronary alpha-adrenoceptors mediate vasoconstriction when beta-adrenoceptors are blocked.